Hanna K. Kanti-Paul
MHML, BBMedSc
Founder & Managing Director | AusNordia
(Co-Owner & Non-Executive Director | HaZ2B Pty Ltd)
Clinical knowledge.
International reach.
Hanna K. Kanti-Paul is a licensed European Healthcare Professional (HCP) and global BioTech/MedTech executive with 30 years of international experience bridging European clinical pathology expertise with commercial translation in Australia.
A foundation built across healthcare.
Holding a Master of Healthcare Management & Leadership (MHML) and a Bachelor of Biomedical Science (BBMedSc), Hanna brings extensive experience across:
- Specialized Clinical Pathology & Hospital Diagnostics
- Enterprise MedTech Commercialization (Abbott, QIAGEN)
- Global Clinical Trial Governance (Type 1 Diabetes, Celiac Disease, Neurology)
- Australian Life Sciences Market Integration & Healthcare Procurement
Built to help good science find its path.
Guided by unwavering integrity, cross-cultural fluency, and authentic Finnish Sisu (reflecting her Finnish background), Hanna established AusNordia to help global research platforms, CDMOs, and university research offices navigate complex healthcare ecosystems and deliver meaningful patient outcomes.